Skip to main content
. 2020 Jul 9;37(9):3775–3790. doi: 10.1007/s12325-020-01409-8

Fig. 2.

Fig. 2

LS mean change (95% CI) from baseline in CAT score over 52 weeks (ITT population). *p < 0.001 for FF/UMEC/VI compared with FF/VI or UMEC/VI; **p = 0.021 for FF/UMEC/VI compared with UMEC/VI. CAT COPD (chronic obstructive pulmonary disease) Assessment Test, CI confidence interval, FF fluticasone furoate, ITT intent to treat, LS least squares, UMEC umeclidinium, VI vilanterol